A high-quality, profitable business with steady sales.
Facts from SEC filings, not a recommendation.
From NICE's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Move the sliders to your own view of NICE. Starting points are the company's recent numbers.
What today's price needs: with a 21% margin and a 12x P/E, sales could shrink about 2.0% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions added 7.1% to their holdings. 143 bought, 200 sold. 2 quarters of net buying in a row.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
2,051 shares at $111.27 · $228K
3 shares at $106.81 · $320
5 shares at $106.81 · $534
3 shares at $106.81 · $320
7,500 shares
554 shares at $0.31 · $170
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page